articleTop 1% cited
SOST is a target gene for PTH in bone
Bone · 2005 · Vol. 37(2) · pp. 148–158
H. J. Keller✉(Novartis Institutes for BioMedical Research)Michaela Kneissel✉(Novartis (Switzerland))
Bone health and treatmentsBone Metabolism and DiseasesBone health and osteoporosis researchSclerostinOsteocyteEndocrinologyInternal medicineCalvariaParathyroid hormoneBone mineralOsteoblastChemistryAnabolism
MeSH terms
Cyclic AMPAnimalsCell LineCycloheximideFemaleFemurColforsinGenetic MarkersGlycoproteinsOsteogenesisOvariectomyParathyroid HormonePeptide FragmentsProtein Synthesis InhibitorsRNA, Messenger
Citations
612
FWCI
10.88
field-weighted impact
References
68
Percentile
99%
vs. same field & year
Citations per year
Cited by
Osteoblast-Osteoclast Communication and Bone Homeostasis
Cells · 2020 · 1,071 citations
The amazing osteocyte
Journal of Bone and Mineral Research · 2010 · 2,184 citations
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
American Journal of Physiology-Renal Physiology · 2010 · 447 citations
Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading
Bone · 2011 · 458 citations
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Bone · 2007 · 701 citations
References
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Endocrine Reviews · 1999 · 2,264 citations
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
The American Journal of Human Genetics · 2001 · 1,008 citations
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
Cell · 1998 · 5,439 citations
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
Journal of Bone and Mineral Research · 1987 · 5,021 citations
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Human Molecular Genetics · 2001 · 1,146 citations
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
The EMBO Journal · 2003 · 1,106 citations
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Proceedings of the National Academy of Sciences · 1998 · 4,244 citations
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Endocrine Reviews · 2002 · 1,739 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
